Reported Sep 28, 2016 · Terminated
Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured…
Genzyme Corporation / Genzyme Biosurgery
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Genzyme Corporation / Genzyme Biosurgery · 1125 Pleasantview Ter · Ridgefield, NJ · 07657-2310
Is this the product you have?
- Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only
- Manufactured byGenzyme Corporation, 500 Kendall Street, Cambridge, MA 02142
- A Sanofi Company Country of OriginUnited Kingdom, NDC 0024-5862-01
- Lot codes and dates
Lot # 5RZ002Exp. 04/18
- Amount recalled
- 9,530 vials
Where it was sold
- Nationwide
Why it was recalled
Labeling: Incorrect or Missing Lot and/or Exp. Date
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Genzyme Corporation / Genzyme Biosurgery recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.